https://www.2minutemedicine.com/dapagliflozin-reduces-the-risk-of-hospitalization-in-patients-with-chronic-kidney-disease/
0
0
12/26/22 at 5:17pm
Organization
2minutemedicine.com
Author
David Xiang
55 words
0
Comments
1. Dapagliflozin reduced the risk of hospitalization in patients with chronic kidney disease (CKD) with and without type 2 diabetes (T2DM). 2. Dapagliflozin also reduced the risk of mortality in patients with CKD. Evidence Rating Level: 1 (Excellent) Study Ru…
You are the first to view
Create an account
or login to join the discussion